Tag Archives: Depression

Vraylar to the Vrescue

Posted on February 26, 2018 by cchrstl

We are now seeing TV ads for Vraylar (generic cariprazine) for “manic or mixed episodes of bipolar I disorder.” An atypical antipsychotic, it alters levels of dopamine and serotonin in the brain. Vraylar was first approved by the FDA to … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Leave a comment

What is Happiness?

Posted on November 6, 2017 by cchrstl

If you want happiness for an hour — take a nap. If you want happiness for a day — go fishing. If you want happiness for a year — inherit a fortune. If you want happiness for a lifetime — … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , | Leave a comment

Are You Depressed?

Posted on October 23, 2017 by cchrstl

The sudden realization that someone might actually enjoy one’s company is a better antidepressant than anything one could get on a prescription. [With thanks to Charles Stross, The Atrocity Archive.] Psychiatry is heavily pushing false data about depression. You should … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Leave a comment

Knock Yourself Out

Posted on August 28, 2017 by cchrstl

The drug Ketamine is now being advertised as a “treatment” for “depression.” Don’t be fooled; this drug is serious business. Ketamine, categorized as a “dissociative anesthetic,” is used in powdered or liquid form as an anesthetic, on animals as well … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | Leave a comment

The Skinny on the Skin Drug

Posted on June 17, 2017 by cchrstl

We saw a TV commercial recently for the drug Otezla® (generic apremilast), from Celgene Corporation, which was approved by the FDA in 2014 for the treatment of symptoms of moderate to severe plaque psoriasis (skin lesions) and psoriatic arthritis. Our … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , | Leave a comment

Terrorized by Climate Change

Posted on June 3, 2017 by cchrstl

The psycho-pharmaceutical industry has jumped full-time onto the climate change bandwagon. You don’t even need to believe in climate change, since there is also the satirical “Climate Change Denial Disorder”. Scholarly articles are being published claiming that climate change affects … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | Leave a comment

This is Your Brain on TMS

Posted on March 6, 2017 by cchrstl

TMS is now available in St. Louis, according to local TV commercials promoting this crippling form of brain stimulation. Techniques such as “transcranial magnetic stimulation” (TMS) are psychiatry’s latest experiment in treatment of the “mentally ill.” In TMS, a magnetic … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Leave a comment

The Screeners are Screaming Again

Posted on March 12, 2016 by cchrstl

The Screeners are Screaming Again Just when you thought that calls for ubiquitous mental health screening was winding down, the U.S. Preventive Services Task Force is calling for widespread depression screening for children. The U.S. Preventive Services Task Force (USPSTF) is made up … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Leave a comment

Risky Business of Sleep Drugs

Posted on March 5, 2016 by cchrstl

Risky Business of Sleep Drugs After reading about the dangers of sleeping pills in the February 2016 edition of Consumer Reports magazine, we thought you might like to know something about that. Some psychotropic drugs are prescribed as sleeping pills. Trazodone, … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , , , | Leave a comment

Another Day Another Anti-depressant (Again)

Posted on February 25, 2016 by cchrstl

Another Day Another Anti-depressant (Again) On July 10, 2015, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole, an atypical antipsychotic) tablets to treat adults with so-called schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | Leave a comment